Skip to content
(Bloomberg) -- Sign up here to receive the Davos Diary, a special daily newsletter that will run from Jan. 20-24.Libya’s biggest oil field began to halt production after armed forces shut down a pipeline, compounding supply disruptions ahead of a conference that aims to broker an end to the OPEC nation’s civil war.The Sharara field, which can pump 300,000 barrels a day, will stop producing once its storage tanks are full, a person familiar with the situation said. Libya’s oil production has already plummeted to the lowest level since September 2016, data compiled by Bloomberg show.Libya’s output has plunged by about 800,000 barrels a day from 1.174 million since an eastern military commander, Khalifa Haftar, blocked exports at ports under his control, according to a statement on Saturday from the state-run National Oil Corp. The NOC declared force majeure, which can allow Libya -- home to Africa’s largest-proven oil reserves -- to...
Reports from Netflix, Intel and Texas Instruments next week may hint at what is to come in the December quarterly earnings season, with some investors wary of possible danger signs that could knock Wall Street after its latest surge to record highs. The S&P 500 has gotten off to a strong start in January, up 3% so far this year, fueled by a truce in the U.S.-China trade war, low interest rates and signs the economy remains healthy. Analysts on average expect reports to show S&P 500 earnings per share fell 0.8% in the fourth quarter, with technology earnings seen up 0.6%, according to IBES data from Refinitiv....
Bank OZK (NASDAQ:OZK) shares fell 3.9% to US$29.25 in the week since its latest yearly results. Revenues came in 2.7......
Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down the charts. An FDA decision or results from a clinical trial have the ability to impact the stock’s direction either way, often dramatically so.On the Street, though, the key is to see beyond the noise and recognize the inherent future potential a company presents. Ignore the price for the moment and concentrate on value, is an oft repeated mantra. Is the company on its way to solving previously solution-free problems? Is it cash strapped or financially secure? Does it have further catalysts down the line? All of these are issues that need to be considered when investing in a stock, and certainly in the volatile world of biotechs.Using TipRanks’ Stock Screener, we were able to zero in on 3 promising tickers in the biotech sector which the analysts...
Today we'll take a closer look at The Greenbrier Companies, Inc. (NYSE:GBX) from a dividend investor's perspective......
The 45-year old marijuana advocacy publication will be getting into the cannabis retail business....
It is a shortened trading week and investors will be focused on earnings and the World Economic Forum taking place in Davos, Switzerland....
